FULL STACK DISCOVERY ENGINE Trademark

Trademark Overview


On Friday, March 26, 2021, a trademark application was filed for FULL STACK DISCOVERY ENGINE with the United States Patent and Trademark Office. The USPTO has given the FULL STACK DISCOVERY ENGINE trademark a serial number of 90606289. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 10, 2022. This trademark is owned by Zentalis Pharmaceuticals, Inc.. The FULL STACK DISCOVERY ENGINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing scientific, pharmaceutical, clinical, and medical research information via the internet; research and development of new products; drug discovery, development, and validation services; pharmaceutical, scientific, medical and clinical research and development services; consulting services in the field of pharmaceutical assessment; validation, screening and mapping of material for drug discovery purposes; providing scientific information and medical research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development in the fields of cancer, infectious diseases, autoimmune diseases, and in the prevention and treatment of pain; providing online information in the fields of cancer, infectious diseases, autoimmune diseases, pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials, and the prevention and treatment of pain, by means of a website; providing information, scien...
full stack discovery engine

General Information


Serial Number90606289
Word MarkFULL STACK DISCOVERY ENGINE
Filing DateFriday, March 26, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, June 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding scientific, pharmaceutical, clinical, and medical research information via the internet; research and development of new products; drug discovery, development, and validation services; pharmaceutical, scientific, medical and clinical research and development services; consulting services in the field of pharmaceutical assessment; validation, screening and mapping of material for drug discovery purposes; providing scientific information and medical research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development in the fields of cancer, infectious diseases, autoimmune diseases, and in the prevention and treatment of pain; providing online information in the fields of cancer, infectious diseases, autoimmune diseases, pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials, and the prevention and treatment of pain, by means of a website; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to differentiated small molecules used for the treatment of cancer, infectious diseases, autoimmune diseases, and in the prevention and treatment of pain

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZentalis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, June 10, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, June 10, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 22, 2021NON-FINAL ACTION E-MAILED
Monday, November 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 30, 2021NEW APPLICATION ENTERED IN TRAM